Fable Therapeutics

Welcome to the new era of Protein Designers.

Fable Therapeutics was founded with a conviction to revolutionize drug discovery through the purposeful integration of AI techniques. ‍

Our cross-functional team of ML scientists and drug hunters collaborate to design novel medicines with expanded therapeutic potential.‍

With this passion and vision, we’re designing the future of drug discovery.

For years, the search for new medicines has been just that - a search.‍
By coupling rapid advancement of machine learning with hard core protein engineering, Fable Therapeutics is writing the next chapter in biologics.

In shaping the future of drug discovery, our team is leveraging advanced computational and AI techniques to surpass traditional limitations and engineer innovative solutions. As protein designers, our aim is to pioneer biomedicines with expanded therapeutic potential.

Our approach allows us to understand proteins in ways we never could before.‍

We are mapping the generalizable rules by which a linear amino acid sequence encodes protein structure and function.‍

Fable protein designers direct our unique ML platform to create novel, programmable protein-based therapeutics.

Geoff  MacKay

Geoff MacKay

  • Chief Executive Officer (CEO)
Philip M.  Kim

Philip M. Kim

  • CTO: Chief Technology Officer
Rhonda  Wideman

Rhonda Wideman

  • Chief Business Officer (CBO)
Vanita D.  Sood

Vanita D. Sood

  • SVP, Head of Drug Discovery
Zack  McNealy

Zack McNealy

  • CFO: Chief Financial Officer
Kirsten  Dupuis

Kirsten Dupuis

  • Chief of Staff